tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Ratios

Compare
339 Followers

Keros Therapeutics Ratios

KROS's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, KROS's free cash flow was decreased by $ and operating cash flow was $0.72. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
19.29 14.25 17.27 21.23 37.27
Quick Ratio
19.29 14.25 17.32 20.97 37.06
Cash Ratio
18.30 13.59 16.86 19.42 37.01
Solvency Ratio
0.09 -4.02 -3.51 -4.79 -5.80
Operating Cash Flow Ratio
1.14 -5.11 -4.23 -5.25 -5.14
Short-Term Operating Cash Flow Coverage
0.00 0.00 -153.98 -72.10 -87.22
Net Current Asset Value
$ 703.82M$ 309.48M$ 256.41M$ 239.36M$ 260.00M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.04 0.04 <0.01 <0.01
Debt-to-Equity Ratio
0.03 0.04 0.05 <0.01 <0.01
Debt-to-Capital Ratio
0.02 0.04 0.05 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.04 <0.01 <0.01
Financial Leverage Ratio
1.08 1.11 1.11 1.05 1.03
Debt Service Coverage Ratio
0.00 0.00 -226.02 -67.42 -104.31
Interest Coverage Ratio
0.00 0.00 -114.79K -14.09K -7.78K
Debt to Market Cap
0.00 0.00 0.01 <0.01 <0.01
Interest Debt Per Share
0.45 0.49 0.53 0.05 0.06
Net Debt to EBITDA
231.12 2.08 2.58 4.06 5.90
Profitability Margins
Gross Profit Margin
99.70%-439.74%0.00%95.53%0.00%
EBIT Margin
-1.30%-101319.21%0.00%-282.23%0.00%
EBITDA Margin
-1.41%-100779.47%0.00%-280.46%0.00%
Operating Profit Margin
-4.80%-112543.71%0.00%-280.46%0.00%
Pretax Profit Margin
6.78%-101319.21%0.00%-282.25%0.00%
Net Profit Margin
1.96%-101319.21%0.00%-292.26%0.00%
Continuous Operations Profit Margin
1.96%-101319.21%0.00%-292.26%0.00%
Net Income Per EBT
28.94%100.00%100.00%103.54%99.62%
EBT Per EBIT
-141.17%90.03%91.19%100.64%97.59%
Return on Assets (ROA)
0.54%-41.35%-34.12%-23.01%-16.84%
Return on Equity (ROE)
0.75%-46.05%-37.73%-24.16%-17.33%
Return on Capital Employed (ROCE)
-1.38%-49.17%-39.55%-23.16%-17.79%
Return on Invested Capital (ROIC)
-0.40%-49.02%-39.43%-23.81%-17.67%
Return on Tangible Assets
0.54%-41.35%-34.12%-23.01%-16.84%
Earnings Yield
0.69%-13.07%-8.64%-4.30%-4.15%
Efficiency Ratios
Receivables Turnover
11.08 0.14 0.00 1.12 0.00
Payables Turnover
0.05 0.15 0.48 0.25 0.28
Inventory Turnover
0.00 0.00 -1.92 0.29 0.41
Fixed Asset Turnover
9.28 <0.01 0.00 8.37 0.00
Asset Turnover
0.27 <0.01 0.00 0.08 0.00
Working Capital Turnover Ratio
0.34 <0.01 0.00 0.08 0.00
Cash Conversion Cycle
-7.88K 196.39 -944.71 88.27 -407.23
Days of Sales Outstanding
32.93 2.64K 0.00 326.87 0.00
Days of Inventory Outstanding
0.00 0.00 -190.07 1.24K 889.27
Days of Payables Outstanding
7.92K 2.44K 754.63 1.48K 1.30K
Operating Cycle
32.93 2.64K -190.07 1.57K 889.27
Cash Flow Ratios
Operating Cash Flow Per Share
1.11 -4.23 -2.78 -2.66 -2.38
Free Cash Flow Per Share
1.07 -4.31 -2.82 -2.71 -2.40
CapEx Per Share
0.04 0.08 0.05 0.04 0.02
Free Cash Flow to Operating Cash Flow
0.97 1.02 1.02 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
28.94 -50.53 -56.46 -60.69 -125.49
Capital Expenditure Coverage Ratio
28.94 -50.53 -56.46 -60.69 -125.49
Operating Cash Flow Coverage Ratio
2.44 -8.62 -5.28 -56.86 -41.04
Operating Cash Flow to Sales Ratio
0.21 -824.56 0.00 -3.09 0.00
Free Cash Flow Yield
7.09%-10.84%-5.88%-4.63%-3.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
144.83 -7.65 -11.58 -23.24 -24.11
Price-to-Sales (P/S) Ratio
2.84 7.75K 0.00 67.92 0.00
Price-to-Book (P/B) Ratio
0.84 3.52 4.37 5.61 4.18
Price-to-Free Cash Flow (P/FCF) Ratio
14.10 -9.22 -17.00 -21.61 -29.41
Price-to-Operating Cash Flow Ratio
13.60 -9.40 -17.30 -21.97 -29.65
Price-to-Earnings Growth (PEG) Ratio
1.50 -0.30 -0.18 1.66 -0.22
Price-to-Fair Value
0.84 3.52 4.37 5.61 4.18
Enterprise Value Multiple
30.04 -5.61 -9.18 -20.16 -18.45
Enterprise Value
-91.27M 854.11M 946.29M 1.14B 828.84M
EV to EBITDA
30.04 -5.61 -9.18 -20.16 -18.45
EV to Sales
-0.43 5.66K 0.00 56.53 0.00
EV to Free Cash Flow
-2.11 -6.73 -13.27 -17.99 -22.29
EV to Operating Cash Flow
-2.03 -6.86 -13.51 -18.28 -22.47
Tangible Book Value Per Share
17.97 11.28 10.99 10.42 16.88
Shareholders’ Equity Per Share
17.97 11.28 10.99 10.42 16.88
Tax and Other Ratios
Effective Tax Rate
0.71 0.00 >-0.01 -0.04 <0.01
Revenue Per Share
5.29 <0.01 0.00 0.86 0.00
Net Income Per Share
0.10 -5.20 -4.15 -2.52 -2.93
Tax Burden
0.29 1.00 1.00 1.04 1.00
Interest Burden
-5.23 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.86 895.75 0.00 2.74 0.00
SG&A to Revenue
0.19 230.69 0.00 1.06 0.00
Stock-Based Compensation to Revenue
0.17 190.48 0.00 0.58 0.00
Income Quality
10.65 0.81 0.67 1.06 0.81
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis